Their action can be either IGF-dependent or independent and altered by various post-translational modifications
What are the side effects of CJC1295 (a growth hormonereleasing hormone analog) and ipamorelin (a growth hormonereleasing peptide)?
It binds all five somatostatin receptors (sst1-5) with affinities comparable to somatostatin, but uniquely also activates the ghrelin receptor (GHSR-1a)
As an effect of ROS on the central nervous system (CNS), which has a high lipid content and high oxygen consumption, the oxidative agents promote lipid peroxidation, leading to membrane fluid loss, suppressing membrane potential, and increasing the accumulation of ions, particularly Ca 2+
So when a product sold as CJC-1295 no-DAC is described using the Teichman half-life or IGF-1 numbers, it is borrowing data from a different molecule with a fundamentally different pharmacokinetic profile
They've got a great experience in this kind of area and a great network of key opinion leaders and experts who can give counsel on this data